Skip to content

Clinical trials

Completed Phase 1 Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 1 Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20162
20191
20201
20211
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AdAlta Limited2
Changchun GeneScience Pharmaceutical Co., Ltd.1
GlaxoSmithKline1
Marilyn Glassberg1
Mayo Clinic1
Medical University of South Carolina1
NYU Langone Health1
Royal Brompton & Harefield NHS Foundation Trust1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial10
Idiopathic Pulmonary Fibrosis2
Bronchiectasis1
Connective Tissue Diseases1
Fibrosis1
Lung Diseases1
Pathologic Processes1
Pulmonary Fibrosis1
Renal Insufficiency, Chronic1
Scleroderma, Diffuse1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.